Building the house of CARDS by phenotyping on the fly
- PMID: 32616600
- PMCID: PMC7450144
- DOI: 10.1183/13993003.02429-2020
Building the house of CARDS by phenotyping on the fly
Abstract
Using clinical, pathophysiological and immunological phenotyping of ARDS to refine management of COVID-19 is urgently required to improve outcomes from refractory hypoxia
Conflict of interest statement
Conflict of interest: R. Rajendram has nothing to disclose.
Comment on
-
COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE. Am J Respir Crit Care Med. 2020. PMID: 32228035 Free PMC article. No abstract available.
-
The perils of premature phenotyping in COVID-19: a call for caution.Eur Respir J. 2020 Jul 23;56(1):2001768. doi: 10.1183/13993003.01768-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32482788 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources